therapy

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis

Understanding MOG Antibody-Associated Disease MOG antibody-associated disease (MOGAD) is increasingly recognized as a unique demyelinating condition in the pediatric population,

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis Read Post »

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis

Clinical Features of MOGAD in Pediatrics MOG-antibody associated disease (MOGAD) presents with a spectrum of symptoms that can vary widely

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis Read Post »

Evaluation of the “RehabXR” virtual reality system for vestibular rehabilitation: evidence of changes in functional brain connectivity in warfighters with chronic mild traumatic brain injury

Study Overview The research focused on evaluating the effectiveness of the “RehabXR” virtual reality system specifically designed for vestibular rehabilitation

Evaluation of the “RehabXR” virtual reality system for vestibular rehabilitation: evidence of changes in functional brain connectivity in warfighters with chronic mild traumatic brain injury Read Post »

Scroll to Top